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Abstract
In this case report we describe a rare case of right atrium myxoma that coexisted with
antiphospholipid syndrome in a young woman. We describe the unusual findings and diagnostic
challenges combined with a review of the literature.
Background
Myxoma is the most common type of primary cardiac
tumors and is usually localized in the left atrium. A right
atrium myxoma is rarely observed. Its clinical presenta-
tion is ranging from an asymptomatic condition or consti-
tutional symptoms to cardiac obstruction or pulmonary
embolism. On the other hand, antiphospholipid syn-
drome is related to thrombotic conditions and the finding
of a cardiac mass would be expected to be a thrombus. A
comprehensive review of the literature reveals a limited
number of cases with coexistence of cardiac myxoma and
antiphospholipid syndrome.
Case report
A 28-year old female patient was admitted to our hospital
because of two-day nausea and pain on the right upper
quadrant of the abdomen. It was mentioned, in her med-
ical history, an episode of acute but transient vision loss
that lasted for a day, five years ago.
On admission, blood pressure was 130/85 mmHg, heart
rate 84 beats/min, respiratory rate 16 breaths/min and
temperature was normal. There were no clinical findings
on cardiac auscultation. Except of mild pain on the right
upper quadrant, the rest of the physical examination was
unremarkable.
Laboratory tests revealed the following results: WBC =
11,6 K/μL, Hb = 13,7 g/dL, Ht = 39,9%, PTL = 95 K/μL,
LDH = 384 U/l, AST = 16 U/l, ALT = 16 U/l, γGT = 10 U/l,
ALP = 58 U/l, bilirubin = 0,73 mg/dl, CRP = 0,07 mg/dl,
ESR = 40 mm and urine test within normal limits. Chest
X-ray didn't show any pathologic finding.
On further investigation, ultrasonography and computed
tomography of the abdominal cavity were obtained and
identified the presence of free fluid around the liver.
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On the second day of the nursery, she had low-grade fever
but her clinical condition worsened, with abdominal ten-
derness, hypotension and tachycardia. The patient was
transferred to the surgical clinic and underwent investiga-
tional laparotomy. There were no special findings, appen-
dectomy was performed and the histological examination
of the appendix, a mesenteric lymph node revealed only
signs of inflammation.
Two days after the surgery, the patient developed tachyp-
nea, tachycardia and fever (temperature of 38,8°C). A
computed tomographic scan of the chest and the abdo-
men was obtained as well as a transthorasic echocardio-
gram in order to rule out pulmonary embolism. The first
imaging study showed infiltrations of the right lower lobe
accompanied by pleural effusion, while the echocardio-
gram revealed the presence of a cardiac mass in the right
atrium, mobile and attached to the interatrial septum (fig-
ure 1). Differential diagnosis was between thrombi and
myxoma. Low-molecular-weight heparin was adminis-
trated to the patient as a therapy for pulmonary embo-
lism.
During her nursery, it was observed that she had steadily
worsening thrombocytopenia and prolonged aPTT, so
more thorough blood tests were done as far as coagulant
disorders are concerned. Based on lupus anticoagulant
(LA) positivity, anticardiolipin (aCL) antibodies and
β2GPI remarkable elevated, the diagnosis of antiphos-
pholipid syndrome was suggested. Because patients with
antiphospholipid syndrome often develop thrombi it was
thought that the mass in the right atrium was a thrombi.
The patient underwent a magnetic resonance imaging, as
a more helpful imaging technique for surgical planning in
order to remove the thrombi. Not only the size and the
location of the cardiac mass were better depicted, but also
pulmonary emboli were revealed on both lower lobes,
especially on the right one (figure 2).
The mass was successfully excised and the histological
examination confirmed the macroscopic diagnosis of
myxoma and not a thrombi. She had a good postoperative
course and was discharged with oral anticoagulant ther-
apy maintaining an international normalized ratio (INR)
between 2,5 and 3. Follow-up echocardiograms showed
no recurrence of the myxoma and repeated blood tests
after 12 weeks confirmed the diagnosis of antiphospholi-
pid syndrome.
Conclusion
Cardiac tumors, either primary or secondary, are uncom-
mon, reported in 0,056% to 1,23% in autopsy series [1].
Primary cardiac tumors are accounting for 76%, in a mul-
ticentre retrospective analysis [2], with 75% of these to be
benign and 50% of the last group to be myxomas. They
occur mainly in women, between the third and sixth dec-
ades of life [3] and they may develop in any chamber of
the heart. The majority is situated in the atria (75% in the
left atrium), with only 5-10% presented in the ventricles
[4]. Atypical locations and multiple myxomas occur in
familiar cases [5].
Macroscopically, there are two types of myxomas: a solid
and round shaped with a nonmobile surface and a poly-
poid one with an asymmetrical, soft and mobile surface
[6]. It is thought that multipotential mesenchymal cells
from embryonic rests give rise to myxomas [4]. Histologi-
cally, they consist of a mixoid matrix composed of an
Echocardiography of a right atrial mass, 2 × 2 cm, attached to  the atrial septum Figure 1
Echocardiography of a right atrial mass, 2 × 2 cm, 
attached to the atrial septum.
MRI showing a mass occupying the right atrium Figure 2
MRI showing a mass occupying the right atrium.Cardiovascular Ultrasound 2009, 7:47 http://www.cardiovascularultrasound.com/content/7/1/47
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acid-mucopolysaccharide-rich stroma and polygonal cells
with scant eosinophillic cytoplasm throughout it. They
may, also, contain cysts, calcifications, areas of haemor-
rhage or extra-medullary heamatopoiesis as well as gland-
like elements [7].
The clinical features depend on the size, the location, the
mobility and the fragility of the mass and they may be
constitutional, obstructive or embolic. The constitutional
symptoms, such as fever, weight loss, anemia, arthralgias
and rash, rely on an immunologic response with an
increase of CRP, IL-6 and γ-globulin [8] due to bleeding
and degeneration within the mass and releasing tumor
fragments. The laboratory tests may mimic those of
autoimmune and rheumatic diseases [9] and this is usu-
ally the main reason for delaying the diagnosis of a
myxoma [6]. In case of a right atrial myxoma, the obstruc-
tion of tricuspid valve can give rise to signs of right-sided
heart failure, such as dyspnea, cyanosis, general edema or
syncope [10]. Moreover, the blockage of the vena cava can
result in a Budd-Chiari syndrome with acute abdominal
pain [11]. The most important life-threatening complica-
tion is pulmonary embolism and it is demonstrated in
40% of patients with cardiac tumors. Rarely, it has been
reported cases of infected right atrial myxomas [12].
As far as the diagnosis is concerned, transthoracic echocar-
diophy is the method of choice for the detection and
description of the size, shape, location, attachment to the
cardiac wall and movement of the myxoma. Transesopha-
geal echocardiography should be considered in case of
clinical suspicion and nondiagnostic transthoracic
echocardiography. Magnetic resonance imaging (MRI) is
a quite expensive but more accurate technique in deter-
mining the structure and special tissue characteristics of
the myxoma, αποτελντας an important role in surgical
planning [13].
The differential diagnosis of a right atrial lession includes
both benign (myxoma, thrombus and vegetations) and
malignant masses and the confirmation of the diagnosis is
the histopathologic examination.
Therapeutic approach consists only of surgical excision of
the mass as soon as possible, especially on its sympto-
matic forms of embolism and heart failure. A better pre-
operative assessment can allow a minimally invasive
approach with video-thoracoscopy [14]. The intra-opera-
tive mortality rate is low and the short and long-term
prognosis excellent. Follow-up echocardiography is
needed to rule out cases of recurrence.
The second clinical condition that was present in our case
report was the antiphospholipid syndrome (APS) which
diagnosis was established six weeks after the surgical
removal of the myxoma. This syndrome is a disorder char-
acterized by recurrent venous or arterial thrombosis and/
or fetal losses associated with characteristic laboratory
abnormalities, such as persistently elevated levels of anti-
bodies directed against membrane anionic phospholipids
(anticardiolipin antibody, antiphosphatidylserine) or
their associated plasma proteins, predominantly beta-2
glycoprotein I (β2GPI), or evidence of a circulating antico-
agulant. It is presented either as primary or secondary to
rheumatic or autoimmune disorders, mainly systemic
lupus erythematosus (SLE) and has been documented a
young female predominance.
The diagnostic criteria are clinical and laboratory ones.
The clinical criteria are: 1) one or more confirmed vascular
thrombotic episode, and 2) pregnancy morbidity. The
laboratory criteria are: elevated levels of 1) aCL antibod-
ies, 2) β2GPI, 3) LA, on at least 2 occasions at least 12
weeks apart. There should be at least one clinical and one
laboratory criterion present for the diagnosis [15].
The medical management of the syndrome is anticoagu-
lant therapy with oral vitamin K antagonists and INR
between 2 and 3, so as to eliminate the thrombosis risk.
In cases of high levels of antibodies but no symptoms,
patients should be treated with low-dose aspirin [16].
Usually patients have only one disease that can explain
their symptoms. In our case report the patient had two dif-
ferent clinical conditions that were responsible for her
symptoms. We can only suggest what was responsible for
her onset clinical symptoms that led to diagnostic laparot-
omy. Some authors have reported that the blockage of the
vena cava by a myxoma, can result in a Budd-Chiari syn-
drome with acute abdominal pain. This scenario can pro-
vide a reasonable explanation but we were not able to
prove it. The other question that rises reasonably is that if
there was a connection between the myxoma and the
presence of antiphospholipid syndrome. While reviewing
the literature, only Quintanilla et al. has reported a similar
case and suggested that that interleukin-6 produced by the
myxoma could trigger an immunological reaction leading
to the primary antiphospholipid syndrome [17]. We have
to emphasize that there was no evidence of antiphosphol-
ipid syndrome relapse after the myxoma excision. On the
other hand many cases of APS in the literature have
reported cardiac thrombi mimicking myxoma [18]. In our
case report if the myxoma was smaller it would result in a
delay of diagnosis, because no surgery would be pre-
formed for the myxoma excision.
In conclusion, it should be mentioned that even though
both right atrial myxoma and antiphospholipid syn-Publish with BioMed Central    and   every 
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drome are uncommon conditions, separately or not, there
should be always clinical suspicion in order to prevent
their serious and probably fatal complications.
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